← All trials
MetabolicActive
Multinational Biological Age Clock Validation Study
The Consortium's flagship trial: validating a shared biological-age clock across seven countries and diverse ancestries: one protocol, one budget, one dataset.
Sponsor
Karolinska Longevity Institute (Stockholm, Sweden)
Lead investigator
Elena Kovač, MD, PhD
Metabolic health researcher focused on early pharmacological intervention in pre-diabetic ageing populations.
Trial sites
- Karolinska Longevity Institute (Stockholm, Sweden)
- Singapore Centre for Healthy Longevity (Singapore, Singapore)
- Mayo Clinic Center for Regenerative Medicine (Rochester, United States)
- Max Planck Institute for Biology of Ageing (Cologne, Germany)
- University of São Paulo, Aging Biology Unit (São Paulo, Brazil)
- Kyoto University Institute for Frontier Life Sciences (Kyoto, Japan)
- University of Cape Town, Longevity Research Group (Cape Town, South Africa)
